• 9 October 2018

    September’s top news stories

    Emerald Health Pharmaceuticals (EHP) started patient enrolment for its Phase I clinical trial of EHP-101 for the treatment of patients with multiple sclerosis (MS) and scleroderma, and Ra Pharmaceuticals reported...

  • 17 September 2018

    The 7 Deadly Sins of Audits and Inspections

    Stuart Halasz, Associate Director, Clinical Quality Management, Merck & Co., Inc., focuses on “7 Deadly Sins” in Audits and Inspections – and thoughts on reducing their occurrence

  • 31 August 2018

    August’s top news stories

    Gradalis started a Phase lll clinical trial of Vigil in combination with irinotecan and temozolomide for the treatment of patients with Ewing’s sarcoma, and Impel NeuroPharma dosed the first subject...


Go Top